$3,872.07 travel Payment -- Pfizer Inc to Dr. Nicole Lopez

Pfizer Inc. pays Rheumatologist Nicole Lopez $3,872.07 for travel and lodging related to Trulicity.

This page provides a detailed analysis of a $3,872.07 travel payment from Pfizer Inc to Dr. Nicole Lopez. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$3,872.07
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanyPfizer Inc
PhysicianDr. Nicole Lopez
NPI Number1181417143
Physician SpecialtyRheumatology
LocationCity, AL
Date of Payment2024-09-22
Related Drug/DeviceTrulicity
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Pfizer Inc made a $3.9K travel payment to Nicole Lopez, a Rheumatology specialist in City, AL. The payment was associated with Trulicity. The payment of $3,872.07 to Dr. Nicole Lopez from Pfizer Inc. for travel and lodging related to Trulicity is a significant amount for a single payment. This payment occurred on September 22, 2024, indicating a recent engagement between the pharma company and the physician. The payment was for 'Travel and Lodging', suggesting expenses incurred for attending events, conferences, or educational programs.

Patient Guidance: What This Payment Means for You

If you are a patient, understand that payments to healthcare providers for travel and lodging may be related to educational events or research. Discuss any concerns about your doctor's relationships with pharmaceutical companies with them directly. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

While travel and lodging payments are common in the pharmaceutical industry, the amount and the potential misalignment between the drug's indication and the physician's specialty warrant a closer look compared to typical payments within Rheumatology.

Regulatory Context: Sunshine Act Requirements

Payments made by manufacturers to physicians must be reported under the Sunshine Act (part of the Affordable Care Act) to ensure transparency in the healthcare industry.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $3.9K payment for?

This was a travel payment of $3.9K from Pfizer Inc to Nicole Lopez, categorized as "Travel and Lodging". It was associated with Trulicity. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Nicole Lopez accept pharmaceutical money?

Yes, Nicole Lopez received this $3.9K payment from Pfizer Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Nicole Lopez's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $3.9K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Rheumatology?

To compare this payment against Rheumatology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Rheumatology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Nicole Lopez's relationship with Pfizer Inc?

The payment amount is substantial for travel and lodging, warranting further investigation into the nature of the expenses. This $3.9K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Rheumatology?

The specific drug mentioned, Trulicity, is a GLP-1 receptor agonist used for type 2 diabetes, which is outside the typical scope of Rheumatology.

What should patients do after learning about this payment?

If you are a patient, understand that payments to healthcare providers for travel and lodging may be related to educational events or research. Discuss any concerns about your doctor's relationships with pharmaceutical companies with them directly.

What else should I know about this travel payment?

Dr. Lopez's specialty is Rheumatology, which may not directly align with the primary indications for Trulicity.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.